Literature DB >> 2456030

Successful prevention of an anaphylactoid reaction to iron dextran.

L C Altman, P E Petersen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2456030     DOI: 10.7326/0003-4819-109-4-346

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  5 in total

Review 1.  Hypersensitivity to intravenous iron: classification, terminology, mechanisms and management.

Authors:  J Szebeni; S Fishbane; M Hedenus; S Howaldt; F Locatelli; S Patni; D Rampton; G Weiss; J Folkersen
Journal:  Br J Pharmacol       Date:  2015-10-25       Impact factor: 8.739

Review 2.  Canadian expert consensus: management of hypersensitivity reactions to intravenous iron in adults.

Authors:  Wendy Lim; Waqqas Afif; Sandra Knowles; Gloria Lim; Yulia Lin; Charmaine Mothersill; Irina Nistor; Faisal Rehman; Christine Song; Ted Xenodemetropoulos
Journal:  Vox Sang       Date:  2019-04-02       Impact factor: 2.144

3.  Intravenous Iron Isomaltoside 1000 Reduces Postoperative Anemia in Patients Undergoing Elective Urologic Surgery and Those with Urosepsis.

Authors:  Hyeok Jun Goh; Ki Soo Lee; Tae Hyo Kim; Kyu Nam Kim; Hyun Jin Lim; Kyu Shik Kim; Won Jae Yang; Jung Ki Jo
Journal:  Drug Des Devel Ther       Date:  2020-12-23       Impact factor: 4.162

4.  Effect of intraoperative intravenous ferric derisomaltose supplementation on reduction of postoperative anemia and transfusion in chronic kidney disease patients after total knee replacement.

Authors:  Jae Hyun Kwon; Yong Hyun Cho; Won Jang; Sun Hee Kim; Hyun Cheol Ko; Woo Hyeong Ko; Young Do Kim
Journal:  Medicine (Baltimore)       Date:  2022-09-02       Impact factor: 1.817

5.  Introducing iron isomaltoside 1000 (Monofer®)-development rationale and clinical experience.

Authors:  Philip A Kalra
Journal:  NDT Plus       Date:  2011-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.